Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Mikulik

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
JAMA Neurology|April 9, 2019
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical TrialJeff S Healey, David J Gladstone, Balakumar Swaminathan, et al.
Stroke|December 15, 2020
Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT StudyTomoyuki Ohara, Bijoy K Menon, Fahad S Al-Ajlan, et al.
Lancet (London, England)|June 10, 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialPeter Kelly, Robin Lemmens, Christian Weimar, et al.
JAMA|September 13, 2018
Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic StrokeBijoy K Menon, Fahad S Al-Ajlan, Mohamed Najm, et al.
Lancet (London, England)|September 5, 2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Hardi Mundl, Eric E Smith, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized TrialScott E Kasner, Pablo Lavados, Mukul Sharma, et al.
European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 7, 2022
Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) surveyXiaochuan Huo, Piers Klein, Raynald, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 23, 2025
Differences in Acute Ischemic Stroke Treatment: A Cross-Sectional Study from International Registry of Stroke Care Quality (RES-Q)Robert Mikulik, Geraldo Neto, Rupal Sedani, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
JAMA Neurology|April 9, 2019
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical TrialJeff S Healey, David J Gladstone, Balakumar Swaminathan, et al.
Stroke|December 15, 2020
Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT StudyTomoyuki Ohara, Bijoy K Menon, Fahad S Al-Ajlan, et al.
Lancet (London, England)|June 10, 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialPeter Kelly, Robin Lemmens, Christian Weimar, et al.
JAMA|September 13, 2018
Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic StrokeBijoy K Menon, Fahad S Al-Ajlan, Mohamed Najm, et al.
Lancet (London, England)|September 5, 2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Hardi Mundl, Eric E Smith, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized TrialScott E Kasner, Pablo Lavados, Mukul Sharma, et al.
European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 7, 2022
Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) surveyXiaochuan Huo, Piers Klein, Raynald, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 23, 2025
Differences in Acute Ischemic Stroke Treatment: A Cross-Sectional Study from International Registry of Stroke Care Quality (RES-Q)Robert Mikulik, Geraldo Neto, Rupal Sedani, et al.
Pageof 14